Yahoo Finance Today's Research Reports on Trending Tickers: bluebird bio and Sarepta Therapeutics
NEW YORK, NY / ACCESSWIRE / October 31, 2018 / U.S. markets rebounded on Tuesday as trade tensions eased after President Trump hinted that the U.S. was prepared to negotiate a trade deal with China. During a Fox News interview with Laura Ingraham, President Trump said the U.S. “will make a great deal with China and it has to be great, because they’ve drained our country.” The Dow Jones Industrial Average gained 1.77 percent to close at 24,874.64, while the S&P 500 Index increased 1.57 percent to close at 2,682.63. The Nasdaq Composite Index jumped 1.58 percent to close at 7,161.65.
“Once again, the month of October has been living up to its frightful reputation for wreaking havoc on stock prices: 1929 and 1987 are prime examples, and we can now safely say that 2018 will also go down in history as an illustration of October’s ability to scare investors. Unfortunately, I don’t foresee this volatility easing too much over the next few weeks,” said chief global market strategist at Invesco, Kristina Hooper.
RDI Initiates Coverage on:
bluebird bio, Inc.
https://rdinvesting.com/news/?ticker=BLUE
Sarepta Therapeutics, Inc.
https://rdinvesting.com/news/?ticker=SRPT
bluebird bio's stock jumped 5.94% Tuesday, to close the day at $110.87. The stock recorded a trading volume of 691,144 shares, which was above its three months average volume of 680,870 shares. In the last year, bluebird bio's shares have traded in a range of 102.21 - 236.17. The share price has gained 8.47% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $133.95 is below its 200-day moving average of $161.50. Shares of bluebird bio have fallen roughly 24.06 percent in the past month and are down 37.75 percent year-to-date.
Access RDI's bluebird bio, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=BLUE
On Tuesday, shares of Sarepta Therapeutics recorded a trading volume of 1,029,295 shares, which was below the three months average volume of 1,105,053 shares. The stock ended the day 6.46% higher at $124.43. The share price has fallen 29.5% from its 52 week high with a 52 week trading range of 46.07 - 176.50. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $140.95 is above its 200-day moving average of $120.56. Shares of Sarepta Therapeutics have fallen roughly 22.96 percent in the past month and are up 123.63 percent year-to-date.
Access RDI's Sarepta Therapeutics, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=SRPT
Our Actionable Research on bluebird bio, Inc. (NASDAQ:BLUE) and Sarepta Therapeutics, Inc. (NASDAQ:SRPT) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
